Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 6, 2004, Pages 686-691

  Brueckmann, Martina ^a   Wolpert, Christian ^a   Bertsch, Thomas ^a   Sueselbeck, Tim ^a   Liebetrau, Claudia ^a   Kaden, Jens J ^a   Huhle, Guenter ^a   Neumaier, Michael ^a   Borggrefe, Martin ^a   Haase, Karl K ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Ablation; Atrial flutter; Inflammation; Metalloproteinases; Wolff Parkinson White syndrome

Indexed keywords

INTERLEUKIN 6; METALLOPROTEINASE; METALLOPROTEINASE 9; MYOGLOBIN; TROPONIN I; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; MALE; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA;

ADULT; AGED; ATRIAL FLUTTER; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CATHETER ABLATION; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOGLOBIN; POSTOPERATIVE COMPLICATIONS; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TREATMENT OUTCOME; TROPONIN I;

EID: 2942527405     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.03371.x     Document Type: Article

References (19)

1. Madrid AH, del Rey JM, Rubi J, Ortega J, Gonzalez Rebollo JM, Seara JG, Ripoll E, Moro C: Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: Approach to size of necrosis. Am Heart J 1998;136:948-955.
2. Manolis AS, Vassilikos V, Maounis T, Melita-Manolis H, Psarros L, Haliasos A, Cokkinos DV: Detection of myocardial injury during radiofrequency catheter ablation by measuring serum cardiac troponin I levels: procedural correlates. J Am Coll Cardiol 1999;34:1099-1105.
3. Carlsson J, Erdogan A, Guettler N, Schulte B, Lay D, Neuzner J, Hamm CW, Pitschner HF: Myocardial injury during radiofrequency catheter ablation: Comparison of focal and linear lesions. Pacing Clin Electrophysiol 2001;24:962-968.
4. Haines DE, Whayne JG, Walker J, Nath S, Bruns DE: The effect of radiofrequency catheter ablation on myocardial creatine kinase activity. J Cardiovasc Electrophysiol 1995;6:79-88.
5. Katritsis D, Hossein-Nia M, Anastasakis A, Poloniecki J, Holt DW, Camm AJ, Ward DE, Rowland E: Myocardial injury induced by radiofrequency and low energy ablation: A quantitative study of CK isoforms, CKMB, and troponin-T concentrations. Pacing Clin Electrophysiol 1998;21:1410-1416.
6. Rao SP, Miller S, Rosenbaum R, Lakier JB: Cardiac troponin I and cardiac enzymes after electrophysiologic studies, ablations, and defibrillator implantations. Am J Cardiol 1999;84:470, A9.
7. Nagase H, Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494.
8. Kaden JJ, Dempfle CE, Sueselbeck T, Brueckmann M, Poerner TC, Haghi D, Haase KK, Borggrefe M: Time dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction. Cardiology 2003;99:140-144.
9. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A: Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-877.
10. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schömig A: Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92:748-755.
11. Lesh MD, Van Hare GF, Schamp DJ, Chien W, Lee MA, Griffin JC, Langberg JJ, Cohen TJ, Lurie KG, Scheinman MM: Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: Results in 100 consecutive patients. J Am Coll Cardiol 1992;19:1303-1309.
12. Manolis AS, Wang PJ, Estes NAM III: Radiofrequency catheter ablation for cardiac tachyarrhythmias. Ann Intern Med 1994;121:452-461.
13. Kannankeril PF, Pahl E, Wax DF: Usefulness of troponin I as a marker of myocardial injury after pediatric cardiac catheterization. Am J Cardiol 2002;90:1128-1132.
14. Deliargyris EN, Raymond RJ, Theoharides TC, Boucher WS, Tate DA, Dehmer GJ: Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am J Cardiol 2000;86:913-918.
15. Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E: Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 1993;126:1299-1304.
16. Peterson JT, Li H, Dillon L, Bryant JW: Evolution of matrix metalloproteinase and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 2000;46:307-315.
17. Romanic AM, Burns-Kurtis CL, Gout B, Berrebi-Bertrand I, Ohlstein EH: Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit. Life Sci 2001;68:799-814.
18. Hirohata S, Kisachi S, Murakami M, Murakami T, Sano I, Watanabe T, Komatsubara I, Kondo J, Tsuji T: Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction. Heart 1997;78:278-284.
19. Herzog E, Gu A, Kohmoto T, Burkhoff D, Hochman JS: Early activation of metalloproteinases after experimental myocardial infarction occurs in infarct and non-infarct zones. Cardiovasc Pathol 1998;7:307-312.